Drugs for Non-small Cell Lung Cancer Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)

SKU ID :99ST-18243185 | Published Date: 10-May-2021 | No. of pages: 152
TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 Drugs for Non-small Cell Lung Cancer Industry 1.1.1 Drugs for Non-small Cell Lung Cancer Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 Drugs for Non-small Cell Lung Cancer in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 Radiofrequency Ablation (RFA)  Market 3.1.2 Radiation Therapy  Market 3.1.3 Chemotherapy  Market 3.1.4 Targeted Therapies  Market 3.1.5 Immunotherapy Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Hospital  Market 4.1.2 Clinic  Market 4.1.3 Others Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 Bristol-Myers Squibb  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 Bristol-Myers Squibb  Profile 11.1.2 Bristol-Myers Squibb  Products & Services Overview 11.1.3 Bristol-Myers Squibb  Main Business 11.1.4 Bristol-Myers Squibb  Business Operation 11.2 GlaxoSmithKline  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 GlaxoSmithKline  Profile 11.2.2 GlaxoSmithKline  Products & Services 11.2.3 GlaxoSmithKline  Main Business 11.2.4 GlaxoSmithKline  Business Operation 11.3 Menarini  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Menarini  Profile 11.3.2 Menarini  Products & Services 11.3.3 Menarini  Main Business 11.3.4 Menarini  Business Operation 11.4 Sanofi  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Sanofi  Profile 11.4.2 Sanofi  Products & Services 11.4.3 Sanofi  Main Business 11.4.4 Sanofi  Business Operation 11.5 Ziopharm Oncology  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Ziopharm Oncology  Profile 11.5.2 Ziopharm Oncology  Products & Services 11.5.3 Ziopharm Oncology  Main Business 11.5.4 Ziopharm Oncology  Business Operation 11.6 Alchemia  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.6.1 Alchemia  Profile 11.6.2 Alchemia  Products & Services 11.6.3 Alchemia  Main Business 11.6.4 Alchemia  Business Operation 11.7 Amgen  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.7.1 Amgen  Profile 11.7.2 Amgen  Products & Services 11.7.3 Amgen  Main Business 11.7.4 Amgen  Business Operation 11.8 Apotex  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.8.1 Apotex  Profile 11.8.2 Apotex  Products & Services 11.8.3 Apotex  Main Business 11.8.4 Apotex  Business Operation 11.9 BioMarin Pharmaceutical  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.9.1 BioMarin Pharmaceutical  Profile 11.9.2 BioMarin Pharmaceutical  Products & Services 11.9.3 BioMarin Pharmaceutical  Main Business 11.9.4 BioMarin Pharmaceutical  Business Operation 11.10 CellAct Pharma  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.10.1 CellAct Pharma  Profile 11.10.2 CellAct Pharma  Products & Services 11.10.3 CellAct Pharma  Main Business 11.10.4 CellAct Pharma  Business Operation 11.11 Cerulean Pharma  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.11.1 Cerulean Pharma  Profile 11.11.2 Cerulean Pharma  Products & Services 11.11.3 Cerulean Pharma  Main Business 11.11.4 Cerulean Pharma  Business Operation 11.12 Cipla  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.12.1 Cipla  Profile 11.12.2 Cipla  Products & Services 11.12.3 Cipla  Main Business 11.12.4 Cipla  Business Operation 11.13 Cornerstone Pharmaceuticals  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.13.1 Cornerstone Pharmaceuticals  Profile 11.13.2 Cornerstone Pharmaceuticals  Products & Services 11.13.3 Cornerstone Pharmaceuticals  Main Business 11.13.4 Cornerstone Pharmaceuticals  Business Operation 11.14 Curis  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.14.1 Curis  Profile 11.14.2 Curis  Products & Services 11.14.3 Curis  Main Business 11.14.4 Curis  Business Operation 11.15 CytRx  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.15.1 CytRx  Profile 11.15.2 CytRx  Products & Services 11.15.3 CytRx  Main Business 11.15.4 CytRx  Business Operation 11.16 Eli Lilly  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.16.1 Eli Lilly  Profile 11.16.2 Eli Lilly  Products & Services 11.16.3 Eli Lilly  Main Business 11.16.4 Eli Lilly  Business Operation 11.17 Exelixis  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.17.1 Exelixis  Profile 11.17.2 Exelixis  Products & Services 11.17.3 Exelixis  Main Business 11.17.4 Exelixis  Business Operation 11.18 Fresenius Kabi  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.18.1 Fresenius Kabi  Profile 11.18.2 Fresenius Kabi  Products & Services 11.18.3 Fresenius Kabi  Main Business 11.18.4 Fresenius Kabi  Business Operation 11.19 Genentech  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.19.1 Genentech  Profile 11.19.2 Genentech  Products & Services 11.19.3 Genentech  Main Business 11.19.4 Genentech  Business Operation 11.20 Hikma Pharmaceuticals  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.20.1 Hikma Pharmaceuticals  Profile 11.20.2 Hikma Pharmaceuticals  Products & Services 11.20.3 Hikma Pharmaceuticals  Main Business 11.20.4 Hikma Pharmaceuticals  Business Operation 11.21 Hospira  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.21.1 Hospira  Profile 11.21.2 Hospira  Products & Services 11.21.3 Hospira  Main Business 11.21.4 Hospira  Business Operation 11.22 Intas Pharmaceuticals  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.22.1 Intas Pharmaceuticals  Profile 11.22.2 Intas Pharmaceuticals  Products & Services 11.22.3 Intas Pharmaceuticals  Main Business 11.22.4 Intas Pharmaceuticals  Business Operation 11.23 Karyopharm Therapeutics  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.23.1 Karyopharm Therapeutics  Profile 11.23.2 Karyopharm Therapeutics  Products & Services 11.23.3 Karyopharm Therapeutics  Main Business 11.23.4 Karyopharm Therapeutics  Business Operation 11.24 Kyowa Hakko Kirin  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.24.1 Kyowa Hakko Kirin  Profile 11.24.2 Kyowa Hakko Kirin  Products & Services 11.24.3 Kyowa Hakko Kirin  Main Business 11.24.4 Kyowa Hakko Kirin  Business Operation 11.25 Ligand Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.25.1 Ligand Pharmaceuticals Profile 11.25.2 Ligand Pharmaceuticals Products & Services 11.25.3 Ligand Pharmaceuticals Main Business 11.25.4 Ligand Pharmaceuticals Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION
LIST OF TABLE TABLE ~ Drugs for Non-small Cell Lung Cancer Industry Dynamics & Regulations List TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ Radiofrequency Ablation (RFA)  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Radiofrequency Ablation (RFA)  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Radiation Therapy  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Radiation Therapy  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Chemotherapy  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Chemotherapy  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Targeted Therapies  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Targeted Therapies  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Immunotherapy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Immunotherapy Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in Volume TABLE ~ Hospital  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Hospital  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Clinic  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinic  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in Volume TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ Bristol-Myers Squibb  Overview List TABLE ~ Products & Services List of Bristol-Myers Squibb  TABLE ~ Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ GlaxoSmithKline  Overview List TABLE ~ Products & Services List of GlaxoSmithKline  TABLE ~ Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Menarini  Overview List TABLE ~ Products & Services List of Menarini  TABLE ~ Business Operation of Menarini  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Sanofi  Overview List TABLE ~ Products & Services List of Sanofi  TABLE ~ Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Ziopharm Oncology  Overview List TABLE ~ Products & Services List of Ziopharm Oncology  TABLE ~ Business Operation of Ziopharm Oncology  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Alchemia  Overview List TABLE ~ Products & Services List of Alchemia  TABLE ~ Business Operation of Alchemia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Amgen  Overview List TABLE ~ Products & Services List of Amgen  TABLE ~ Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Apotex  Overview List TABLE ~ Products & Services List of Apotex  TABLE ~ Business Operation of Apotex  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ BioMarin Pharmaceutical  Overview List TABLE ~ Products & Services List of BioMarin Pharmaceutical  TABLE ~ Business Operation of BioMarin Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ CellAct Pharma  Overview List TABLE ~ Products & Services List of CellAct Pharma  TABLE ~ Business Operation of CellAct Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Cerulean Pharma  Overview List TABLE ~ Products & Services List of Cerulean Pharma  TABLE ~ Business Operation of Cerulean Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Cipla  Overview List TABLE ~ Products & Services List of Cipla  TABLE ~ Business Operation of Cipla  (Sales Revenue, Cost, Gross Margin) TABLE ~ Cornerstone Pharmaceuticals  Overview List TABLE ~ Products & Services List of Cornerstone Pharmaceuticals  TABLE ~ Business Operation of Cornerstone Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Curis  Overview List TABLE ~ Products & Services List of Curis  TABLE ~ Business Operation of Curis  (Sales Revenue, Cost, Gross Margin) TABLE ~ CytRx  Overview List TABLE ~ Products & Services List of CytRx  TABLE ~ Business Operation of CytRx  (Sales Revenue, Cost, Gross Margin) TABLE ~ Eli Lilly  Overview List TABLE ~ Products & Services List of Eli Lilly  TABLE ~ Business Operation of Eli Lilly  (Sales Revenue, Cost, Gross Margin) TABLE ~ Exelixis  Overview List TABLE ~ Products & Services List of Exelixis  TABLE ~ Business Operation of Exelixis  (Sales Revenue, Cost, Gross Margin) TABLE ~ Fresenius Kabi  Overview List TABLE ~ Products & Services List of Fresenius Kabi  TABLE ~ Business Operation of Fresenius Kabi  (Sales Revenue, Cost, Gross Margin) TABLE ~ Genentech  Overview List TABLE ~ Products & Services List of Genentech  TABLE ~ Business Operation of Genentech  (Sales Revenue, Cost, Gross Margin) TABLE ~ Hikma Pharmaceuticals  Overview List TABLE ~ Products & Services List of Hikma Pharmaceuticals  TABLE ~ Business Operation of Hikma Pharmaceuticals  (Sales Revenue, Cost, Gross Margin) TABLE ~ Hospira  Overview List TABLE ~ Products & Services List of Hospira  TABLE ~ Business Operation of Hospira  (Sales Revenue, Cost, Gross Margin) TABLE ~ Intas Pharmaceuticals  Overview List TABLE ~ Products & Services List of Intas Pharmaceuticals  TABLE ~ Business Operation of Intas Pharmaceuticals  (Sales Revenue, Cost, Gross Margin) TABLE ~ Karyopharm Therapeutics  Overview List TABLE ~ Products & Services List of Karyopharm Therapeutics  TABLE ~ Business Operation of Karyopharm Therapeutics  (Sales Revenue, Cost, Gross Margin) TABLE ~ Kyowa Hakko Kirin  Overview List TABLE ~ Products & Services List of Kyowa Hakko Kirin  TABLE ~ Business Operation of Kyowa Hakko Kirin  (Sales Revenue, Cost, Gross Margin) TABLE ~ Ligand Pharmaceuticals Overview List TABLE ~ Products & Services List of Ligand Pharmaceuticals TABLE ~ Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin) TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales by Company 2016-2021E, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales by Company 2016-2021E, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share by Company 2016-2021E, in Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global Drugs for Non-small Cell Lung Cancer Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients